Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study Evaluating the Effect of Physician Education on Smoking Cessation Counselling

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Assuta Hospital Systems
ClinicalTrials.gov Identifier:
NCT01432912
First received: September 11, 2011
Last updated: June 18, 2013
Last verified: September 2011
  Purpose

The purpose of the study is to see if a short seminar educating physicians about smoking cessation counselling will effectively improve their smoking counselling cessation practices.


Condition Intervention
Smoking
Behavioral: Physician Educational Seminar

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Subject)
Official Title: Pilot Study Evaluating the Influence of Physician Education Regarding the 5A's Smoking Cessation Counselling Strategy, as Evaluated by Patient Interpretation of the Strategy Principles

Resource links provided by NLM:


Further study details as provided by Assuta Hospital Systems:

Primary Outcome Measures:
  • Patient assessment questionnaires [ Time Frame: Within a month after the seminar. ] [ Designated as safety issue: No ]

Enrollment: 98
Study Start Date: September 2011
Study Completion Date: January 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Patients Behavioral: Physician Educational Seminar
Participating Physicians will attend an hour long seminar on smoking cessation counselling.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients 18yrs and over that visit the participating physicians and agree to compete the study questionnaire
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01432912

Locations
Israel
Maccabi Healthcare Services
Modiin, Israel
Sponsors and Collaborators
Assuta Hospital Systems
  More Information

No publications provided

Responsible Party: Assuta Hospital Systems
ClinicalTrials.gov Identifier: NCT01432912     History of Changes
Other Study ID Numbers: Maccabi-14/2011
Study First Received: September 11, 2011
Last Updated: June 18, 2013
Health Authority: Israel: Ministry of Health

ClinicalTrials.gov processed this record on November 20, 2014